Nuvation Bio (NUVB) Earnings Date & Reports

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NUVB is expected to report earnings to fall 1.13% to -14 cents per share on May 07

Nuvation Bio NUVB Stock Earnings Reports

Q1'25

Est.

$-0.15

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.01

Q2'24

Missed

by $1.83

Q1'24

Beat

by $0.02

The last earnings report on March 06 showed earnings per share of -15 cents, missing the estimate of -14 cents. With 5.90M shares outstanding, the current market capitalization sits at 835.58M.

View a ticker or compare two or three

Compare

NUVB